Lancet Journal has listed 8 ‘urgent steps’ to tackle COVID-19 crisis in India
The comment in 'The Lancet' journal was authored by as many as 21 authors, including Biocon chief Kiran Mazumdar-Shaw.
The comment in 'The Lancet' journal was authored by as many as 21 authors, including Biocon chief Kiran Mazumdar-Shaw.
On Friday, the Customised Crash course programme for COVID-19 frontline workers at 11:00 a.m. will be launched by Prime Minister…
The US CDC has classified the Delta, a highly transmissible COVID-19 variant, as a 'variant of concern'.
Pune-based vaccine maker Serum Institute of India (SII) is expected to begin clinical trials for the Novavax Covid vaccine for…
Black Fungus infection needs to be caught as early as possible because it is aggressive and dead tissue has to…
As people are now fleeting to get vaccines, there is a severe shortage of COVID-19 vaccines. Other than mass production…
The disappointing efficacy of the shot referred to as CVnCoV emerged from an interim analysis supported 134 Covid-19 cases within…
SII is yet to receive raw materials from the US needed to supply the Novavax vaccine.
In September 2020, Novavax announced a manufactured agreement with Serum Institute of India for its COVID-19 vaccine candidate NVX-CoV2373.
Residents of a housing society in Mumbai’s Kandivali area claim to be victims of an elaborate vaccination scam where they…
With the decreasing cases of the COVID-19 the situation in Delhi, AIIMS has decided to restart its OPD services in…
The AstraZeneca Plc’s antibody cocktail was only 33 per cent effective at preventing COVID-19 symptoms in people who had been…